Chen Chuan Hao, Zhou You Lang, Wu Ya Fang, Cao Yi, Gao Jin Song, Tang Jin Bo
Department of Hand Surgery, Hand Surgery Research Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
J Hand Surg Am. 2009 Dec;34(10):1777-84.e1. doi: 10.1016/j.jhsa.2009.07.015.
Transforming growth factor (TGF)-beta is considered to be responsible for the formation of scars such as adhesions around healing digital flexor tendons. We proposed to deliver microRNAs (miRNAs) to silence expression of the TGF-beta1 gene and to investigate the effectiveness of miRNAs in down-regulation of the TGF-beta1 gene in vitro and in vivo.
We designed and engineered 4 miRNAs according to genetic sequences of chicken TGF-beta1. Four plasmid vectors harboring the respective engineered miRNAs and 1 control vector were constructed. We transfected 30 wells of cultured tenocytes with these vectors and harvested them 48 hours later. The gene expression levels were quantified using real-time polymerase chain reactions. Subsequently, the miRNA that most effectively silenced TGF-beta gene in vitro was tested on 25 chickens in vivo. The miRNA and control vectors were injected into the injured tendons, respectively. At 1 and 6 weeks after surgery, the tendons were analyzed for gene expression and protein production.
In both in vitro and in vivo settings, delivery of miRNA to the tendon substantially down-regulated expression of the TGF-beta gene but did not affect expression of the collagen I gene. In the healing tendon, TGF-beta gene expression was significantly down-regulated by 50% to 60% at 1 and 6 weeks. At 6 weeks, the collagen III gene expression was significantly down-regulated by 55% at 6 weeks and the connective tissue growth factor gene was significantly down-regulated by 25%. At 6 weeks, TGF-beta protein was substantially decreased.
MicroRNA significantly down-regulates expression of the TGF-beta in vitro and in vivo. Application of miRNA did not down-regulate expression of the collagen I, but downregulated the collagen III gene. Application of miRNA treatment to modulate TGF-beta expression holds great promise in preventing tendon adhesion formation.
转化生长因子(TGF)-β被认为是导致诸如愈合中的指屈肌腱周围粘连等瘢痕形成的原因。我们提议递送微小RNA(miRNA)以沉默TGF-β1基因的表达,并研究miRNA在体外和体内下调TGF-β1基因的有效性。
我们根据鸡TGF-β1的基因序列设计并构建了4种miRNA。构建了分别携带各自工程化miRNA的4种质粒载体和1种对照载体。我们用这些载体转染30孔培养的肌腱细胞,并在48小时后收获。使用实时聚合酶链反应对基因表达水平进行定量。随后,在25只鸡体内测试了在体外最有效地沉默TGF-β基因的miRNA。分别将miRNA和对照载体注射到受伤的肌腱中。在手术后1周和6周,分析肌腱的基因表达和蛋白质产生情况。
在体外和体内环境中,向肌腱递送miRNA均显著下调了TGF-β基因的表达,但不影响I型胶原基因的表达。在愈合的肌腱中,TGF-β基因表达在1周和6周时显著下调了50%至60%。在6周时,III型胶原基因表达在6周时显著下调了55%,结缔组织生长因子基因显著下调了25%。在6周时,TGF-β蛋白大幅减少。
微小RNA在体外和体内均显著下调TGF-β的表达。miRNA的应用未下调I型胶原的表达,但下调了III型胶原基因的表达。应用miRNA治疗来调节TGF-β表达在预防肌腱粘连形成方面具有很大的前景。